The course is open for all students that are enrolled in the minor Molecular Biotechnology and who have followed the previous courses ‘Exploitation of Natural Products’ and ‘Biotechnology: from Gene to Bio-based Product’. Participation in Medical Biotechnology 1 is a prerequisite for continuing with Medical Biotechnology 2.
Coordinator: Prof. Dr. A.H. Meijer
The medical biotechnology course consists of 2 parts: Medical Biotechnology 1 and 2 (3 EC each). It will provide a fascinating overview of how living cells and animal models are used to investigate and produce pharmaceutical and diagnostic products that help treat and prevent human diseases. This course will demonstrate how an integrated and multidisciplinary approach can yield critical new leads to our understanding of disease generation. By stimulating lectures from key players in the research field students will become familiar with the techniques, approaches and inventions leading to future generations of pharmaceuticals. The students will also receive lectures from specialists of companies in the Leiden Bio Science Park to show applications in biotechnology. Topics that will be covered include the drug discovery pipeline, vaccine development, biopharmaceuticals, transgenesis, gene therapy, stem cell therapy and tissue engineering.
Getting a broad understanding of the value of biomedical research for biotechnological applications. To see links with the fundamental research in biomedical sciences and industrial applications e.g. in the Leiden Bioscience Park.
Understanding of the state of the art in biomedical research areas, including drug and target discovery, vaccine development, biopharmaceuticals, transgenesis, gene therapy, stem cell research and tissue engineering. Insight into current limitations and future prospects of biotechnological applications in medicine. Ability to apply the knowledge gained from the course lectures in a short literature research and powerpoint presentation about a relevant topic of choice.
From 14 November 2016 – 25 November 2016. Lectures by invited speakers and time for self-study on a daily basis. Participation in lectures is obligatory. Exam: 21 November. Powerpoint presentations: 22 and 23 November preparation (self study), 24 and 25 November presentations. The detailed schedule will be provided on Blackboard.
Mode of instruction
Medical biotechnology 1 and 2 both comprise series of obligatory lectures provided by invited specialist speakers will be combined with self study from the following book: Medical Biotechnology, Pongracz and Keen, Churchill Livingstone (Elsevier). The students will have to prepare for the lectures by submitting multiple choice tests through Blackboard. Students taking the Medical Biotechology 2 course additionally have to prepare a powerpoint presentation on a topic of choice in the field of medical biotechnology.
Exam 60%, powerpoint presentation (including participation in discussions) 30%, Blackboard tests 10%. The minimal grade for the exam should be a 5.
The course information, time table, test questions and powerpoint presentations of the lectures will be available via Blackboard.
Obligatory book: Medical Biotechnology, Pongracz and Keen, Churchill Livingstone (Elsevier).
Register for this course via Usis and enroll in Blackboard.
Exchange and Study Abroad students, please see the Prospective students website for information on how to apply.